Document is current
Any future updates will be listed below
-
Authors
Hung, Chin-Sheng
Shen, Hsieh-Tsung
Wang, Pei-Yu
Su, Chih-Ming
Hsu, Wei-Wen
Chien, Kuan-Yu
Han, Cai-Sia
Liao, Li-Min
Lin, Ruo-Kai
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 8 July 2025
First Online: 21 July 2025
Declarations
:
: The study has been approved by the Taipei Medical University—Joint Institutional Review Board and the Institutional Review Board. Written informed consent was obtained from all patients.
: Not applicable.
: Part authors are employees of EG BioMed Co. Ltd. and EG BioMed US Inc., whose company funded this study. HTS, RKL are employees of EG BioMed Co. Ltd. and EG BioMed US Inc., HTS, CMS, CSH and RKL hold stock in EG BioMed Co. Ltd. and EG BioMed US Inc., and report other support from EG BioMed Co. Ltd. and EG BioMed US Inc., during the conduct of the study. In addition, RKL has multiple patents in the field of cancer detection pending to EG BioMed Co. Ltd. The remaining authors declare no competing interests.
